Skip to main navigation Skip to search Skip to main content

Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab

  • Lee S. Schwartzberg
  • , Kurt W. Tauer
  • , Robert C. Hermann
  • , Grace Makari-Judson
  • , Claudine Isaacs
  • , J. Thaddeus Beck
  • , Virginia Kaklamani
  • , Edward J. Stepanski
  • , Hope S. Rugo
  • , Wei Wang
  • , Katherine Bell-McGuinn
  • , Jeffrey J. Kirshner
  • , Peter Eisenberg
  • , Richard Emanuelson
  • , Mark Keaton
  • , Ellis Levine
  • , Diana C. Medgyesy
  • , Rubina Qamar
  • , Alexander Starr
  • , Sunhee Kwon Ro
    • Nathalie A. Lokker, Clifford A. Hudis

Research output: Contribution to journal › Article › peer-review

77   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology